62 related articles for article (PubMed ID: 3112998)
1. Inhibition in maturation of nascent DNA fragments in cultured mouse FM3A cells after treatment with DNA-damaging agents.
Hyodo M; Yamashita M; Suzuki K
Tokai J Exp Clin Med; 1986 Aug; 11(3):163-70. PubMed ID: 3112998
[TBL] [Abstract][Full Text] [Related]
2. Effect of DNA-damaging agents on DNA replication and cell-cycle progression of cultured mouse mammary carcinoma cells.
Kanno S; Hyodo M; Suzuki K; Ohkido M
Jpn J Cancer Res; 1985 Apr; 76(4):289-96. PubMed ID: 3924703
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin-mediated DNA double-strand breaks in replicating but not in quiescent cells of the yeast Saccharomyces cerevisiae.
Frankenberg-Schwager M; Kirchermeier D; Greif G; Baer K; Becker M; Frankenberg D
Toxicology; 2005 Sep; 212(2-3):175-84. PubMed ID: 15950355
[TBL] [Abstract][Full Text] [Related]
4. Formation by bifunctional furocoumarins of DNA crosslinks and their repair in cultured mouse embryo fibroblasts.
Szafarz D
Biochem Int; 1986 Nov; 13(5):735-9. PubMed ID: 3814154
[TBL] [Abstract][Full Text] [Related]
5. Formation and repair of DNA interstrand cross-links in relation to cytotoxicity and unscheduled DNA synthesis induced in control and mutant human cells treated with cis-diamminedichloroplatinum(II).
Plooy AC; van Dijk M; Berends F; Lohman PH
Cancer Res; 1985 Sep; 45(9):4178-84. PubMed ID: 3928152
[TBL] [Abstract][Full Text] [Related]
6. Psoralen plus near-ultraviolet light: a possible new method for measuring DNA repair synthesis.
Heimer YM; Kol R; Shiloh Y; Riklis E
Radiat Res; 1983 Sep; 95(3):541-9. PubMed ID: 6310675
[TBL] [Abstract][Full Text] [Related]
7. Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents.
Ihnat MA; Lariviere JP; Warren AJ; La Ronde N; Blaxall JR; Pierre KM; Turpie BW; Hamilton JW
Clin Cancer Res; 1997 Aug; 3(8):1339-46. PubMed ID: 9815817
[TBL] [Abstract][Full Text] [Related]
8. Defective removal of DNA cross-links in a repair-deficient mutant of Chinese hamster cells.
Meyn RE; Jenkins SF; Thompson LH
Cancer Res; 1982 Aug; 42(8):3106-10. PubMed ID: 6807537
[TBL] [Abstract][Full Text] [Related]
9. Differential sensitivity to mitomycin C between human RSa cell line and its derivative UVr-1.
Hiwasa T; Chen Z; Nomura J; Yamamori H; Tashiro T; Nakajima N; Suzuki N
Anticancer Res; 1999; 19(5B):3915-20. PubMed ID: 10628331
[TBL] [Abstract][Full Text] [Related]
10. Interactions of mitomycin C with mammalian DNA detected by alkaline elution.
Dorr RT; Bowden GT; Alberts DS; Liddil JD
Cancer Res; 1985 Aug; 45(8):3510-6. PubMed ID: 3926301
[TBL] [Abstract][Full Text] [Related]
11. Abnormal regulation of DNA replication and increased lethality in ataxia telangiectasia cells exposed to carcinogenic agents.
Jaspers NG; de Wit J; Regulski MR; Bootsma D
Cancer Res; 1982 Jan; 42(1):335-41. PubMed ID: 6172195
[TBL] [Abstract][Full Text] [Related]
12. Lack of correlation between p53 protein level and sensitivity of DNA-damaging agents in keratinocytes carrying adenovirus E1a mutants.
Sanchez-Prieto R; Lleonart M; Ramón y Cajal S
Oncogene; 1995 Aug; 11(4):675-82. PubMed ID: 7651731
[TBL] [Abstract][Full Text] [Related]
13. Maturation of nascent DNA fragment is disturbed after treatment of cultured mouse FM3A cells with 8-methoxypsoralen plus near-ultraviolet radiation.
Hyodo M; Hori T; Kanno S; Zanma T; Suzuki K
Biochim Biophys Acta; 1983 May; 740(1):46-51. PubMed ID: 6405787
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric characterization of the response of Fanconi's anemia cells to mitomycin C treatment.
Kaiser TN; Lojewski A; Dougherty C; Juergens L; Sahar E; Latt SA
Cytometry; 1982 Mar; 2(5):291-7. PubMed ID: 6804195
[TBL] [Abstract][Full Text] [Related]
15. UVC inhibits HIF-1alpha protein translation by a DNA damage- and topoisomerase I-independent pathway.
Rapisarda A; Melillo G
Oncogene; 2007 Oct; 26(48):6875-84. PubMed ID: 17496931
[TBL] [Abstract][Full Text] [Related]
16. Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines.
Mamenta EL; Poma EE; Kaufmann WK; Delmastro DA; Grady HL; Chaney SG
Cancer Res; 1994 Jul; 54(13):3500-5. PubMed ID: 8012973
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of DNA cross-linking in normal and neoplastic mouse tissues following treatment with cis-diamminedichloroplatinum(II) in vivo.
Murray D; Jenkins WT; Meyn RE
Cancer Res; 1985 Dec; 45(12 Pt 1):6446-52. PubMed ID: 4063992
[TBL] [Abstract][Full Text] [Related]
18. Hypersensitivity of Brca1-deficient MEF to the DNA interstrand crosslinking agent mitomycin C is associated with defect in homologous recombination repair and aberrant S-phase arrest.
Yun J; Zhong Q; Kwak JY; Lee WH
Oncogene; 2005 Jun; 24(25):4009-16. PubMed ID: 15782115
[TBL] [Abstract][Full Text] [Related]
19. Induction of fos RNA by DNA-damaging agents.
Hollander MC; Fornace AJ
Cancer Res; 1989 Apr; 49(7):1687-92. PubMed ID: 2466559
[TBL] [Abstract][Full Text] [Related]
20. Increased sensitivity of human colon cancer cells to DNA cross-linking agents after GRP78 up-regulation.
Belfi CA; Chatterjee S; Gosky DM; Berger SJ; Berger NA
Biochem Biophys Res Commun; 1999 Apr; 257(2):361-8. PubMed ID: 10198218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
